Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
We examine altcoins with strong funding, evaluating how capital enables development pace, partnerships, and long-term roadmap execution.
17,339 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Ripple expands its blockchain pilot by entering Singapore's BLOOM sandbox, testing RLUSD-backed trade settlements on ...
When the youngest of Jolie and Pitt reach adulthood, a custody phase ends—and so does a big chapter of family finance...
A Reynolds director recently bought about $99,000 of REYN stock. This article breaks down what reynolds stock directo...
When celebrity legal battles heat up, the billable clock often steals the spotlight. This article breaks down what a ...
As the partial government shutdown stretches into weeks, houston airport, with nearly 40% TSA absences, becomes a foc...
In 2025, the U.S. minted 441,000 new millionaires as the median American wealth contracted, underscoring a split econ...
As a CFP®, I see recurring investing mistakes that erode gains. This practical guide shows how to spot them and turn ...
A laid-off professional returns to work for $18,000 less annually and faces the looming question: how will this affec...
When fear takes the wheel, investors often forget the basics. This guide lays out three practical reminders to stay t...
AMD and Palantir diverge in the AI rally as analysts set new price targets, outlining two distinct paths for these AI...
Coinbase again declines to back the revamped Digital Asset Market Clarity Act, citing significant concerns as lawmake...